Revolymer focuses on "Removable" chewing gum

By Neil Merrett

- Last updated on GMT

Related tags Confectionery

Research company Revolymer intends to step up production of a new
polymer that it claims could form the basis of an easily removable
chewing gum.

The group, which has been researching the polymers for over two years, hopes to increase its research and development workforce to meet the growing demands of the market.

While the gum remains at the prototype stage, the company revealed that they would continue working on the modified gum base until fully satisfied with the product.

Roger Pettman, the company's chief executive told Confectionerynews.com​ that they are looking to move their formulation to the next level.

"As well as making the gum easier to remove, we also are looking at ensuring we get the best flavour possible as well as taste retention, as such we wish to find the best formulation possible,"​ he said.

Pettmann revealed that its expansion coincided with the growing number of applications the product could be used with.

"We are expanding to focus on the growing application of our polymers which have uses from not just the confectionery industry, but to medicines and even anti-graffiti paints,"​ he said

The company was formed in 2005 as an off shoot of The University of Bristol's Revolymer group, set up to re-design existing commodity polymers with enhanced physical properties.

By moving to its plant in Mostyn, North Wales, the company aims to create 50 R and D positions to push forward with large scale production over the next three years.

Related topics Ingredients

Related news

Related products

show more

What consumers are looking for in alcohol drinks

What consumers are looking for in alcohol drinks

Content provided by ADM | 12-Apr-2024 | Application Note

Are you ready to understand the consumer insights driving the future of the alcoholic beverage market? We've assembled a consumer insights report...

Redefine resilience with IMMUSE

Redefine resilience with IMMUSE

Content provided by Kyowa Hakko (US) | 02-Apr-2024 | White Paper

IMMUSETM is a universal postbiotic — the first of its kind to activate pDC cells for year-round immune support.

Related suppliers

Follow us

Products

View more

Webinars